vs
Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $13.7M, roughly 1.7× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs 14.6%, a 61.1% gap on every dollar of revenue. GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-2.1M).
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
GENC vs XLO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $13.7M |
| Net Profit | $3.4M | $10.4M |
| Gross Margin | 28.7% | — |
| Operating Margin | 13.2% | -86.5% |
| Net Margin | 14.6% | 75.7% |
| Revenue YoY | -25.0% | — |
| Net Profit YoY | -9.8% | 179.1% |
| EPS (diluted) | $0.23 | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.6M | $13.7M | ||
| Q3 25 | $18.8M | $19.1M | ||
| Q2 25 | $27.0M | $8.1M | ||
| Q1 25 | $38.2M | $2.9M | ||
| Q4 24 | $31.4M | — | ||
| Q3 24 | $20.9M | — | ||
| Q2 24 | $25.6M | — | ||
| Q1 24 | $40.7M | — |
| Q4 25 | $3.4M | $10.4M | ||
| Q3 25 | $1.9M | $-16.3M | ||
| Q2 25 | $3.8M | $-15.8M | ||
| Q1 25 | $6.1M | $-13.3M | ||
| Q4 24 | $3.8M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $6.2M | — |
| Q4 25 | 28.7% | — | ||
| Q3 25 | 24.2% | — | ||
| Q2 25 | 26.5% | — | ||
| Q1 25 | 29.7% | — | ||
| Q4 24 | 27.6% | — | ||
| Q3 24 | 25.6% | — | ||
| Q2 24 | 23.9% | — | ||
| Q1 24 | 30.3% | — |
| Q4 25 | 13.2% | -86.5% | ||
| Q3 25 | -1.2% | -10.1% | ||
| Q2 25 | 11.6% | -177.7% | ||
| Q1 25 | 17.0% | -472.7% | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | 17.4% | — |
| Q4 25 | 14.6% | 75.7% | ||
| Q3 25 | 10.2% | -85.4% | ||
| Q2 25 | 14.2% | -196.0% | ||
| Q1 25 | 16.0% | -452.7% | ||
| Q4 24 | 12.1% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | 10.0% | — | ||
| Q1 24 | 15.3% | — |
| Q4 25 | $0.23 | $-3.74 | ||
| Q3 25 | $0.13 | $-0.11 | ||
| Q2 25 | $0.26 | $-0.16 | ||
| Q1 25 | $0.42 | $-0.18 | ||
| Q4 24 | $0.26 | — | ||
| Q3 24 | $0.10 | — | ||
| Q2 24 | $0.17 | — | ||
| Q1 24 | $0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.7M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $215.2M | $35.3M |
| Total Assets | $228.9M | $154.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $147.7M | $137.5M | ||
| Q3 25 | $136.3M | $103.8M | ||
| Q2 25 | $136.0M | $121.6M | ||
| Q1 25 | $143.7M | $89.1M | ||
| Q4 24 | $130.1M | — | ||
| Q3 24 | $115.4M | — | ||
| Q2 24 | $116.6M | — | ||
| Q1 24 | $117.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $215.2M | $35.3M | ||
| Q3 25 | $211.8M | $-8.1M | ||
| Q2 25 | $209.9M | $7.1M | ||
| Q1 25 | $206.1M | $10.7M | ||
| Q4 24 | $200.0M | — | ||
| Q3 24 | $196.1M | — | ||
| Q2 24 | $194.7M | — | ||
| Q1 24 | $192.1M | — |
| Q4 25 | $228.9M | $154.7M | ||
| Q3 25 | $222.6M | $133.7M | ||
| Q2 25 | $220.2M | $133.8M | ||
| Q1 25 | $223.9M | $103.7M | ||
| Q4 24 | $218.2M | — | ||
| Q3 24 | $208.1M | — | ||
| Q2 24 | $201.8M | — | ||
| Q1 24 | $206.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.1M | $-2.0M |
| Free Cash FlowOCF − Capex | $10.1M | $-2.1M |
| FCF MarginFCF / Revenue | 43.0% | -15.3% |
| Capex IntensityCapex / Revenue | 4.1% | 0.7% |
| Cash ConversionOCF / Net Profit | 3.23× | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-3.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | $-2.0M | ||
| Q3 25 | $-275.0K | $-17.5M | ||
| Q2 25 | $-23.9M | $-14.5M | ||
| Q1 25 | $12.4M | $29.0M | ||
| Q4 24 | $14.8M | — | ||
| Q3 24 | $-3.2M | — | ||
| Q2 24 | $-1.0M | — | ||
| Q1 24 | $11.7M | — |
| Q4 25 | $10.1M | $-2.1M | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $-24.4M | $-14.9M | ||
| Q1 25 | $12.3M | $29.0M | ||
| Q4 24 | $14.5M | — | ||
| Q3 24 | $-3.3M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $11.7M | — |
| Q4 25 | 43.0% | -15.3% | ||
| Q3 25 | -6.8% | — | ||
| Q2 25 | -90.4% | -184.0% | ||
| Q1 25 | 32.2% | 988.3% | ||
| Q4 24 | 46.1% | — | ||
| Q3 24 | -15.8% | — | ||
| Q2 24 | -5.6% | — | ||
| Q1 24 | 28.7% | — |
| Q4 25 | 4.1% | 0.7% | ||
| Q3 25 | 5.4% | 0.0% | ||
| Q2 25 | 1.8% | 5.0% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 3.23× | -0.19× | ||
| Q3 25 | -0.14× | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | 2.04× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | -2.22× | — | ||
| Q2 24 | -0.41× | — | ||
| Q1 24 | 1.87× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
